Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNγ-dependent iNOS expression in the vasculature of healthy mice

Blood

Volumn 111, Issue 10, 2008, Pages 5187-5194

  Morton, Jonathan ^a   Coles, Barbara ^a   Wright, Kate ^a   Gallimore, Awen ^a   Morrow, Jason D ^b   Terry, Erin S ^b   Anning, Peter B ^a   Morgan, B Paul ^a   Dioszeghy, Vincent ^a   Kühn, Hartmut ^c   Chaitidis, Pavlos ^c   Hobbs, Adrian J ^d   Jones, Simon A ^a   O'Donnell, Valerie B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b VANDERBILT UNIVERSITY   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; COMPLEMENT COMPONENT C5; ENDOTOXIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; DEGRANULATION; HEREDITY; HYPERTENSION; MOUSE; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; VASCULARIZATION; VASOCONSTRICTION; ANIMAL; BACTERIAL INFECTION; BLOOD PRESSURE; BLOOD VESSEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HYPOTENSION; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

ANIMALS; BACTERIAL INFECTIONS; BLOOD PRESSURE; BLOOD VESSELS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOTENSION; INFLAMMATION; INTERFERON TYPE II; MICE; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; VASOCONSTRICTION;

EID: 46749101053     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-117283     Document Type: Article

References (42)

1. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
2. McBride AG, Brown GC. Activated human neutrophils rapidly break down nitric oxide. FEBS Letters. 1997;417:231-234.
3. Clark SR, Coffey MJ, Maclean RM, et al. Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and my-eloperoxidase-deficient human neutrophils. J Immunol (Baltimore, MD). 2002;169:5889-5896.
4. Zou M, Martin C, Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem. 1997;378:707-713.
5. Zou MH, Leist M, Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol. 1999;154:1359-1365.
6. Baldus S, Eiserich JP, Mani A, et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest. 2001;108:1759-1770.
7. Baldus S, Heitzer T, Eiserich JP, et al. Myeloper- oxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med. 2004;37:902-911.
8. Ma XL, Tsao PS, Viehman GE, Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res. 1991;69:95-106.
9. Ohlstein EH, Nichols AJ. Rabbit polymorpho- nuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res. 1989;65:917-924.
10. Abe Y, Saito T, Kuroda S, Ishibashi T, Keitoku M, Maruyama Y. Unstimulated polymorphonuclear neutrophils regulate proximal coronary arterial tone. Intl J Cardiol. 1996;55:15-27.
11. De Kimpe SJ, Van Heuven-Nolsen D, Nijkamp FP. Acetylcholine-induced relaxation in bovine isolated mesenteric arteries is suppressed by polymorphonuclear leukocytes. Brit J Pharmacol. 1993;109:8-13.
12. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (Baltimore, MD). 1997;158:1383-1391.
13. Vassiloyanakopoulos AP, Okamoto S, Fierer J. The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc Natl Acad Sci U S A. 1998;95:7676-7681.
14. Afanasyeva M, Georgakopoulos D, Fairweather D, Caturegli P, Kass DA, Rose NR. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knock- out mice. Circulation. 2004;110:2910-2917.
15. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J. 2003;17:773-775.
16. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (New York, NY). 1993;259:1739-1742.
17. Ismail HF, Fick P, Zhang J, Lynch RG, Berg DJ. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helico- bacter. J Immunol (Baltimore, MD). 2003;170: 3782-3789.
18. Selsted ME, Miller CW, Novotny MJ, Morris WL, Koeffler HP. Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels. Blood. 1993; 82:1317-1322.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350- 4354.
20. Morrow JD, Minton TA. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. J Chromatog. 1993;612:179-185.
21. Medgyesi GA, Fust G, Gergely J, Bazin H. Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. Immunochemistry. 1978;15:125-129.
22. Harris RI, Stone PC, Stuart J. An improved chromogenic substrate endotoxin assay for clinical use. J Clin Pathol. 1983;36:1145-1149.
23. Daley JM, Reichner JS, Mahoney EJ, et al. Modulation of macrophage phenotype by soluble product(s) released from neutrophils. J Immunol (Baltimore, MD). 2005;174:2265-2272.
24. Coles B, Lewis R, Anning PB, et al. CD59 or C3 are not requred for angiotensin Il-dependent hypertension or hypertrophy in mice. Immunology. 2007;121:518-525.
25. Anning PB, Coles B, Morton J, et al. Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors. Blood. 2006;108:4059-4062.
26. Shoenfeld Y, Alkan ML, Asaly A, Carmeli Y, Katz M. Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol. 1988;41:273-277.
27. Berliner S, Shapira I, Toker S, Melamed S, Shirom A, Rogowski O. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation: a new look in the era of microinflammation. Blood Cells Mol Diseases. 2005;34:135-140.
28. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient- new views of an old problem. Hematology Am Soc Hematol Educ Program. 2001:113-139.
29. Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genetics. 2002;30:295-300.
30. Omert L, Tsukada K, Hierholzer C, et al. A role of neutrophils in the down-regulation of IL-6 and CD14 following hemorrhagic shock. Shock (Augusta, GA). 1998;9:391-396.
31. Steinshamn S, Bemelmans MH, Buurman WA, Waage A. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity. Cytokine. 1995;7:50-56.
32. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415-3421.
33. Kies MS, Luedke DW, Boyd JF, McCue MJ. Neutropenic enterocolitis: two case reports of long- term survival following surgery. Cancer. 1979;43:730-734.
34. Preisler HD, Goldstein IM, Henderson ES. Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer. 1970;26:1076-1081.
35. Feld R, Bodey GP. Infections in patients with malignant lymphoma treated with combination chemotherapy. Cancer. 1977;39:1018-1025.
36. Bafica A, Scanga CA, Serhan C, et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest. 2005;115:1601-1606.
37. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280:15267-15278.
38. McCartney-Francis NL, Wahl SM. Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1. J Immunol (Baltimore, MD). 2002;169:5941-5947.
39. Brown GC, Foxwell N, Moncada S. Transcellular regulation of cell respiration by nitric oxide generated by activated macrophages. FEBS Letters. 1998;439:321-324.
40. Geng Y, Hansson GK, Holme E. Interferon- gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 1992;71:1268-1276.
41. Koh KP, Wang Y, Yi T, et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest. 2004;114:846-856.
42. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945-1956.